Inhibition of Human Neutrophil Elastase by Pentacyclic TriterpenesReportar como inadecuado

Inhibition of Human Neutrophil Elastase by Pentacyclic Triterpenes - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.


Inhibiting human neutrophil elastase HNE is a promising strategy for treating inflammatory lung diseases, such as H1N1 and SARS virus infections. The use of sivelestat, the only clinically registered synthesized HNE inhibitor, is largely limited by its risk of organ toxicity because it irreversibly inhibits HNE. Therefore, potent reversible HNE inhibitors are promising alternatives to sivelestat.

Methods and Results

An in vitro HNE inhibition assay was employed to screen a series of triterpenes. Six pentacyclic triterpenes, but not tetracyclic triterpenes, significantly inhibited HNE. Of these pentacyclic triterpenes, ursolic acid exhibited the highest inhibitory potency IC50 = 5.51 µM. The HNE inhibitory activity of ursolic acid was further verified using a mouse model of acute smoke-induced lung inflammation. The results of nuclear magnetic resonance and HNE inhibition kinetic analysis showed that the pentacyclic triterpenes competitively and reversibly inhibited HNE. Molecular docking experiments indicated that the molecular scaffold, 28-COOH, and a double bond at an appropriate location in the pentacyclic triterpenes are important for their inhibitory activity.


Our results provide insights into the effects of pentacyclic triterpenes on lung inflammatory actions through reversible inhibition of HNE activity.

Autor: Li Feng, Xiaoyu Liu, Weiliang Zhu, Fujiang Guo, YingchunWu, Rui Wang, Kaixian Chen, Cheng Huang , Yiming Li



Documentos relacionados